{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:00:56Z","timestamp":1792598456903,"version":"4.5.0"},"reference-count":55,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi251588-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Associations between chronic kidney disease (CKD) severity and incident cognitive impairment have not been evaluated in a cohort of patients with CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251588-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate associations between CKD severity, based on the estimated glomerular filtration rate (eGFR) and urinary protein to creatinine ratio (UPCR), and incident cognitive impairment in a cohort of patients with CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251588-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This cohort study investigated 5607 participants with CKD from the ongoing Chronic Renal Insufficiency Cohort (CRIC) Study who were enrolled between 2003 to 2008 and 2013 to 2015. Statistical analysis was conducted from August 2024 to December 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251588-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Estimated glomerular filtration rate and UPCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251588-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Global cognition and domains of verbal memory and delayed recall, attention and processing speed, and executive function were evaluated using the Modified Mini-Mental Status Examination, Buschke Selective Reminding test, and Trail Making Tests A and B, respectively. For each test, impairment was defined as a score at least 1 SD worse than the baseline cohort mean. After those with cognitive impairment at baseline were excluded, Cox proportional hazards regression models tested associations of baseline eGFR and UPCR, individually and together, with time to cognitive impairment after adjusting for demographic, lifestyle, and clinical risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251588-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The 5607 CRIC participants included 3159 men (56.3%), the mean (SD) cohort age was 59.6 (10.8) years at baseline, and the median follow-up was 6 years (range, 0.5-16 years) for the Modified Mini-Mental State Examination, 4 years (range, 0.5-13 years) for the Buschke Selective Reminding Test, and 4 years (range, 0.5-13 years) for Trail Making Tests A and B. In multivariable-adjusted analyses, each 1 SD higher log-transformed UPCR was associated with 21% increased risk of impairments in attention and processing speed (hazard ratio [HR], 1.21; 95% CI, 1.05-1.41;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.01) and 16% increased risk of impairment in executive function (HR, 1.16; 95% CI, 1.02-1.31;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.02). Each 1 SD lower eGFR was associated with 21% increased risk of impairment in attention and processing speed (HR, 1.21; 95% CI, 1.05-1.38;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.006). Findings for UPCR remained nominally significant after further adjustment for eGFR, while eGFR findings were attenuated on adjustment for UPCR. Patients with a combined eGFR less than 60 mL\/min\/1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      and UPCR of 150 mg\/g or more had a significant 38% increased risk of impairment in global cognition (HR, 1.38; 95% CI, 1.05-1.82;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.003) compared with those with an eGFR of 60 mL\/min\/1.74 m\n                      <jats:sup>2<\/jats:sup>\n                      or more and UPCR less than 150 mg\/g.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251588-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This cohort study of patients with CKD suggests that a more advanced CKD stage was associated with increased incidence of cognitive impairment. These findings underscore CKD severity as a risk factor for cognitive decline across the CKD spectrum.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.59834","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T16:30:19Z","timestamp":1771345819000},"page":"e2559834","source":"Crossref","is-referenced-by-count":6,"title":["Chronic Kidney Disease Severity and Risk of Cognitive Impairment"],"prefix":"10.1001","volume":"9","author":[{"given":"Zhijie","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana"},{"name":"Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, College of Medicine, University of Illinois Chicago, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Yaffe","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of California, San Francisco"},{"name":"Department of Neurology, University of California, San Francisco"},{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changwei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Peter O\u2019Donnell Jr. School of Public Health at UT Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cissy","family":"Xiao","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, College of Medicine, University of Illinois Chicago, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Pan","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, College of Medicine, University of Illinois Chicago, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Sun","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, College of Medicine, University of Illinois Chicago, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda H.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"He","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Peter O\u2019Donnell Jr. School of Public Health at UT Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard G.","family":"Jaar","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heedeok","family":"Han","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Kiryluk","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboob","family":"Rahman","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, University Hospitals Cleveland Medical Center, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panduranga","family":"Rao","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Ricardo","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, College of Medicine, University of Illinois Chicago, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vallabh O.","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Biochemistry, University of New Mexico, Albuquerque"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, College of Medicine, University of Illinois Chicago, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Taliercio","sequence":"additional","affiliation":[{"name":"Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjula","family":"Kurella Tamura","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Unruh","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, University of New Mexico, Albuquerque"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Weir","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Lash","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, College of Medicine, University of Illinois Chicago, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia A.","family":"Bazzano","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Medicine, O\u2019Donnell Jr School of Public Health, UT Southwestern Medical Center, Dallas, Texas"},{"name":"Department of Epidemiology, O\u2019Donnell Jr School of Public Health, UT Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine T.","family":"Mills","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanika N.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, College of Medicine, University of Illinois Chicago, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Chronic Renal Insufficiency Cohort (CRIC) Study Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda H.","family":"Anderson","sequence":"additional","affiliation":[{"name":"for the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Appel","sequence":"additional","affiliation":[{"name":"for the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[{"name":"for the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie L.","family":"Cohen","sequence":"additional","affiliation":[{"name":"for the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Dember","sequence":"additional","affiliation":[{"name":"for the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Go","sequence":"additional","affiliation":[{"name":"for the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Lash","sequence":"additional","affiliation":[{"name":"for the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboob","family":"Rahman","sequence":"additional","affiliation":[{"name":"for the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panduranga S.","family":"Rao","sequence":"additional","affiliation":[{"name":"for the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vallabh O.","family":"Shah","sequence":"additional","affiliation":[{"name":"for the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Unruh","sequence":"additional","affiliation":[{"name":"for the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"issue":"2","key":"zoi251588r1","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"issue":"8","key":"zoi251588r2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41581-025-00967-w","article-title":"Chronic kidney disease and dementia: an epidemiological perspective.","volume":"21","author":"Ikram","year":"2025","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"zoi251588r3","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1097\/01.ASN.0000131529.60019.FA","article-title":"Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study.","volume":"15","author":"Seliger","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"24","key":"zoi251588r4","doi-asserted-by":"publisher","first-page":"e2956","DOI":"10.1212\/WNL.0000000000012113","article-title":"Kidney function, kidney function decline, and the risk of dementia in older adults: a registry-based study.","volume":"96","author":"Xu","year":"2021","journal-title":"Neurology"},{"issue":"6","key":"zoi251588r5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1053\/j.ajkd.2020.03.015","article-title":"Albuminuria and estimated GFR as risk factors for dementia in midlife and older age: findings from the ARIC study.","volume":"76","author":"Scheppach","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"zoi251588r6","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1212\/WNL.0b013e3181b72629","article-title":"Kidney function is associated with the rate of cognitive decline in the elderly.","volume":"73","author":"Buchman","year":"2009","journal-title":"Neurology"},{"issue":"11","key":"zoi251588r7","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1111\/j.1532-5415.2008.01936.x","article-title":"Kidney function and cognitive performance and decline in older men.","volume":"56","author":"Slinin","year":"2008","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"zoi251588r8","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1111\/jgs.12986","article-title":"Higher levels of cystatin C are associated with worse cognitive function in older adults with chronic kidney disease: the Chronic Renal Insufficiency Cohort Cognitive Study.","volume":"62","author":"Yaffe","year":"2014","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"zoi251588r9","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1532-5415.2009.02670.x","article-title":"Chronic kidney disease and cognitive function in older adults: findings from the Chronic Renal Insufficiency Cohort Cognitive Study.","volume":"58","author":"Yaffe","year":"2010","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"zoi251588r10","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1053\/j.ajkd.2011.05.027","article-title":"Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States.","volume":"58","author":"Kurella Tamura","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"zoi251588r11","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006693","article-title":"Albuminuria increases the risks for both Alzheimer disease and vascular dementia in community-dwelling Japanese elderly: the Hisayama Study.","volume":"7","author":"Takae","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"zoi251588r12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/aje\/kwp429","article-title":"Invited commentary: albuminuria and microvascular disease of the brain\u2014a shared pathophysiology.","volume":"171","author":"Knopman","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"8","key":"zoi251588r13","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.2215\/CJN.00070109","article-title":"Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function.","volume":"4","author":"Lash","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"19","key":"zoi251588r14","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C\u2013based equations to estimate GFR without race.","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"issue":"4S","key":"zoi251588r17","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"issue":"5","key":"zoi251588r18","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1053\/j.ajkd.2024.09.017","article-title":"Methods for diagnosing proteinuria\u2014when to use which test and why: a review.","volume":"85","author":"Hodel","year":"2025","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"zoi251588r19","doi-asserted-by":"publisher","first-page":"6960","DOI":"10.1002\/alz.14182","article-title":"Clonal hematopoiesis of indeterminate potential is associated with reduced risk of cognitive impairment in patients with chronic kidney disease.","volume":"20","author":"Xiao","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"4","key":"zoi251588r20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.ajkd.2023.03.012","article-title":"Blood pressure, incident cognitive impairment, and severity of CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.","volume":"82","author":"Babroudi","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"zoi251588r21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ekir.2016.10.007","article-title":"Inflammatory markers and risk for cognitive decline in chronic kidney disease: the CRIC Study.","volume":"2","author":"Kurella Tamura","year":"2017","journal-title":"Kidney Int Rep"},{"issue":"4","key":"zoi251588r22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/jamainternmed.2013.1868","article-title":"Hearing loss and cognitive decline in older adults.","volume":"173","author":"Lin","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"9","key":"zoi251588r23","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1212\/01.wnl.0000182897.18229.ec","article-title":"Statins and cognitive function in the elderly: the Cardiovascular Health Study.","volume":"65","author":"Bernick","year":"2005","journal-title":"Neurology"},{"issue":"7","key":"zoi251588r24","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1681\/ASN.2021111435","article-title":"Association of proximal tubular secretory clearance with long-term decline in cognitive function.","volume":"33","author":"Lidgard","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"zoi251588r25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10985-007-9057-x","article-title":"A latent process model for dementia and psychometric tests.","volume":"14","author":"Ganiayre","year":"2008","journal-title":"Lifetime Data Anal"},{"issue":"4","key":"zoi251588r26","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/j.1541-0420.2006.00573.x","article-title":"A nonlinear model with latent process for cognitive evolution using multivariate longitudinal data.","volume":"62","author":"Proust","year":"2006","journal-title":"Biometrics"},{"issue":"26","key":"zoi251588r27","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1002\/sim.4035","article-title":"Semi-parametric latent process model for longitudinal ordinal data: application to cognitive decline.","volume":"29","author":"Jacqmin-Gadda","year":"2010","journal-title":"Stat Med"},{"key":"zoi251588r28","doi-asserted-by":"publisher","year":"2021","journal-title":"N Engl J Med","DOI":"10.1056\/NEJMoa2103753"},{"issue":"2","key":"zoi251588r29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/hr.2008.27","article-title":"Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk.","volume":"32","author":"Ito","year":"2009","journal-title":"Hypertens Res"},{"issue":"1","key":"zoi251588r30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1161\/HYPERTENSIONAHA.123.19943","article-title":"Cerebral small vessel disease, hypertension, and vascular contributions to cognitive impairment and dementia.","volume":"81","author":"Hainsworth","year":"2024","journal-title":"Hypertension"},{"issue":"21","key":"zoi251588r31","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.030780","article-title":"Cardiovascular disease and Alzheimer\u2019s disease: the heart-brain axis.","volume":"12","author":"Saeed","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"zoi251588r32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1210\/endrev\/bnaa025","article-title":"Microvascular dysfunction in diabetes mellitus and cardiometabolic disease.","volume":"42","author":"Horton","year":"2021","journal-title":"Endocr Rev"},{"key":"zoi251588r33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fcvm.2020.00096","article-title":"Cerebrovascular disease and cognition in chronic kidney disease patients.","volume":"7","author":"Miglinas","year":"2020","journal-title":"Front Cardiovasc Med"},{"issue":"8","key":"zoi251588r34","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/CIRCRESAHA.122.321762","article-title":"Hypertension as cardiovascular risk factor in chronic kidney disease.","volume":"132","author":"Burnier","year":"2023","journal-title":"Circ Res"},{"issue":"3","key":"zoi251588r35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1053\/j.ajkd.2022.07.013","article-title":"Association of kidney function measures with signs of neurodegeneration and small vessel disease on brain magnetic resonance imaging: the Atherosclerosis Risk in Communities (ARIC) study.","volume":"81","author":"Scheppach","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"zoi251588r36","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: classification, concentration, and interindividual variability.","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int"},{"key":"zoi251588r37","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2016.07.026","article-title":"The transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and L-arginine with the human blood\u2013brain barrier in vitro.","author":"Watson","journal-title":"Brain Res"},{"issue":"7","key":"zoi251588r38","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/ki.2010.194","article-title":"FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease.","volume":"78","author":"Yilmaz","year":"2010","journal-title":"Kidney Int"},{"key":"zoi251588r39","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.redox.2018.03.010","article-title":"The uremic toxin hippurate promotes endothelial dysfunction via the activation of Drp1-mediated mitochondrial fission.","volume":"16","author":"Huang","year":"2018","journal-title":"Redox Biol"},{"issue":"1","key":"zoi251588r40","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1038\/s41598-022-08387-7","article-title":"Blood-brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins.","volume":"12","author":"Hernandez","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"zoi251588r41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12974-023-02703-2","article-title":"Chronic kidney disease promotes cerebral microhemorrhage formation.","volume":"20","author":"Fang","year":"2023","journal-title":"J Neuroinflammation"},{"issue":"7","key":"zoi251588r42","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S1474-4422(19)30079-1","article-title":"Small vessel disease: mechanisms and clinical implications.","volume":"18","author":"Wardlaw","year":"2019","journal-title":"Lancet Neurol"},{"issue":"4","key":"zoi251588r43","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.tins.2020.11.003","article-title":"A vessel for change: endothelial dysfunction in cerebral small vessel disease.","volume":"44","author":"Quick","year":"2021","journal-title":"Trends Neurosci"},{"issue":"1","key":"zoi251588r44","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1038\/s41598-018-37935-3","article-title":"neurological sequel of chronic kidney disease: from diminished acetylcholinesterase activity to mitochondrial dysfunctions, oxidative stress and inflammation in mice brain.","volume":"9","author":"Mazumder","year":"2019","journal-title":"Sci Rep"},{"issue":"8","key":"zoi251588r45","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41581-020-0266-9","article-title":"Mechanisms of cognitive dysfunction in CKD.","volume":"16","author":"Viggiano","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"zoi251588r46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213321","article-title":"Circulating fibroblast growth factor 23 levels and incident dementia: the Framingham Heart Study.","volume":"14","author":"McGrath","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"zoi251588r47","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12882-018-1094-z","article-title":"The role of klotho in chronic kidney disease.","volume":"19","author":"Zou","year":"2018","journal-title":"BMC Nephrol"},{"issue":"11","key":"zoi251588r48","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1210\/jc.2014-1736","article-title":"Plasma parathyroid hormone is associated with vascular dementia and cerebral hyperintensities in two community-based cohorts.","volume":"99","author":"Hagstr\u00f6m","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"zoi251588r49","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/ajh\/hpw164","article-title":"Inflammation and arterial stiffness in chronic kidney disease: findings from the CRIC Study.","volume":"30","author":"Peyster","year":"2017","journal-title":"Am J Hypertens"},{"issue":"10","key":"zoi251588r50","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41581-024-00848-8","article-title":"Sleep disorders in chronic kidney disease.","volume":"20","author":"Lyons","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"zoi251588r51","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1055\/s-0037-1604351","article-title":"Sleep disturbance, cognitive decline, and dementia: a review.","volume":"37","author":"Wennberg","year":"2017","journal-title":"Semin Neurol"},{"key":"zoi251588r52","doi-asserted-by":"publisher","DOI":"10.1177\/2048004016677687","article-title":"Neurological complications in chronic kidney disease.","author":"Arnold","journal-title":"JRSM Cardiovasc Dis"},{"issue":"6","key":"zoi251588r53","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1053\/j.ajkd.2013.07.013","article-title":"Comparison of associations of urine protein-creatinine ratio versus albumin-creatinine ratio with complications of CKD: a cross-sectional analysis.","volume":"62","author":"Fisher","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"10S","key":"zoi251588r54","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.20259y5kcnm9","article-title":"Comparison of urine albumin-to-creatinine ratio (UACR) and protein-to-creatinine ratio (UPCR) as markers of kidney and cardiovascular disease risk: a multinational, patient-level meta-analysis.","volume":"36","author":"Heerspink","year":"2025","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"zoi251588r55","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/aje\/kwr243","article-title":"Misuse of the linear mixed model when evaluating risk factors of cognitive decline.","volume":"174","author":"Proust-Lima","year":"2011","journal-title":"Am J Epidemiol"},{"key":"zoi251588r15","unstructured":"2024 Annual data report. US Renal Data System. Accessed June 2, 2025. https:\/\/usrds-adr.niddk.nih.gov\/2024"},{"key":"zoi251588r16","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International supplements. 2013;3:1-150. Accessed January 7, 2026. https:\/\/kdigo.org\/wp-content\/uploads\/2017\/02\/KDIGO_2012_CKD_GL.pdf","DOI":"10.1016\/j.kisu.2017.10.001"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2845146\/huang_2026_oi_251588_1772732870.36851.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T19:00:22Z","timestamp":1772737222000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2845146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.59834","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]}}}